Get started
Work

Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm

Year: 2017
Type: article
Abstract: Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm *AML transformed from antecedent hematologic disorder or AML/MPN/MDS after prior cytotoxic therapy.ALT: alanine aminotransferase; AML: acute myeloid leukemia; AST: aspartate aminotransferase; CMML-2: chronic myelomonocytic leukemia-2; MDS-EB-2: myelodysplastic syndrome with excess blasts-2; TRM: treatment-related mortality; WBC: white blood cell count.
DOI: 10.3324/haematol.2017.182642
Authors: Roland B. Walter, Megan Othus, Kaysey F. Orlowski, Emily N. McDaniel, Bart L. Scott, Pamela S. Becker, Mary-Elizabeth M. Percival, Paul C. Hendrie, Bruno C. Medeiros, Michael T. Chiarella, Arthur C. Louie, Elihu H. Estey
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,157
OpenAlex ID: W2775314788
FWCI: 2.715
Cites: 15
Cited by: 22
Related to: 10